Post Marketing study to evaluate the safety and efficacy of Glutazene sachetsSingle Arm Post Marketing Study to Evaluate Safety and Efficacy of Glutazene sachets in Adult Patients with ulcer
Phase 4
Completed
- Conditions
- Health Condition 1: K928- Other specified diseases of the digestive system
- Registration Number
- CTRI/2020/08/027039
- Lead Sponsor
- Tablets India Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1.Patients with confirmed endoscopic results for acid peptic disease, exhibiting symptoms of gastritis, gastric ulcers, duodenal ulcers and GERD
2.Male or female patients Ë?18 years and Ë? 65 years of age
3.Patient on treatment with proton pump inhibitor (PPI) recently(not more than 7 days) or newly starting PPI as part of acid peptic ulcer treatment
4.No allergies to any of the ingredients of the study drug
5.Patient willing to sign informed consent and are willing to follow the protocols requirements
Exclusion Criteria
Not provided
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method